1. 17 Venous thromboembolism – Prevention is better than cure. (March 2022) Authors: Shailendranath, L.; Ting, S. Journal: European journal of obstetrics, gynecology, and reproductive biology Issue: Volume 270(2022) Page Start: e29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 18 Antenatal corticosteroids for fetal lung maturation - Are we doing it right?. (March 2022) Authors: Shailendranath, L.; Ting, S. Journal: European journal of obstetrics, gynecology, and reproductive biology Issue: Volume 270(2022) Page Start: e48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 20 Cold coagulation treatment of cervical intraepithelial neoplasia (CIN): Human papillomavirus (HPV) Evidence of cure. (March 2022) Authors: Ting, S.; Shailendranath, L.; Hickey, K. Journal: European journal of obstetrics, gynecology, and reproductive biology Issue: Volume 270(2022) Page Start: e49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 28 Gestational diabetes mellitus: Is it a threat?. (March 2022) Authors: Ting, S.; Shailendranath, L.; O'Riordan, M. Journal: European journal of obstetrics, gynecology, and reproductive biology Issue: Volume 270(2022) Page Start: e49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 39 Molecular dissection of the impact of frequent genetic alterations on the response of head and neck cancers to anti-epidermal growth factor receptor-directed therapies. Issue 5 (May 2015) Authors: Ting, S.; Gauler, T.; Breitenbücher, F.; Vossebein, I.; Hoffarth, S.; Markowetz, J.; Lang, S.; Bergmann, C.; Brandau, S.; Abu-Jawad, J.; Schmid, K.W.; Schuler, M.; Kasper, S. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 39 Molecular dissection of the impact of frequent genetic alterations on the response of head and neck cancers to anti-epidermal growth factor receptor-directed therapies. Issue 5 (May 2015) Authors: Pogorzelski, M.; Ting, S.; Gauler, T.; Breitenbücher, F.; Vossebein, I.; Hoffarth, S.; Markowetz, J.; Lang, S.; Bergmann, C.; Brandau, S.; Abu-Jawad, J.; Schmid, K.W.; Schuler, M.; Kasper, S. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 39 Molecular dissection of the impact of frequent genetic alterations on the response of head and neck cancers to anti-epidermal growth factor receptor-directed therapies. Issue 5 (May 2015) Authors: Pogorzelski, M.; Ting, S.; Gauler, T.; Breitenbücher, F.; Vossebein, I.; Hoffarth, S.; Markowetz, J.; Lang, S.; Bergmann, C.; Brandau, S.; Abu-Jawad, J.; Schmid, K.W.; Schuler, M.; Kasper, S. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A randomised controlled trial of peri‐operative lidocaine infusions for open radical prostatectomy1. (8th January 2016) Authors: Weinberg, L.; Rachbuch, C.; Ting, S.; Howard, W.; Yeomans, M.; Gordon, I.; McNicol, L.; James, K.; Story, D.; Christophi, C. Journal: Anaesthesia Issue: Volume 71:Number 4(2016:Apr.) Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas. Issue 1 (April 2015) Authors: Reis, H.; Herold, T.; Ting, S.; Worm, K.; Huber, U.; Christoph, D.C.; Eberhardt, W.E.; Kostbade, K.; Kasper, S.; Stamatis, G.; Welter, S.; Darwiche, K.; Karpf-Wissel, R.; Theegarten, D.; Schmid, K.W.; Schuler, M.; Wiesweg, M. Journal: Lung cancer Issue: Volume 88:Issue 1(2015:Apr.) Page Start: 34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas. Issue 1 (April 2015) Authors: Reis, H.; Herold, T.; Ting, S.; Worm, K.; Huber, U.; Christoph, D.C.; Eberhardt, W.E.; Kostbade, K.; Kasper, S.; Stamatis, G.; Welter, S.; Darwiche, K.; Karpf-Wissel, R.; Theegarten, D.; Schmid, K.W.; Schuler, M.; Wiesweg, M. Journal: Lung cancer Issue: Volume 88:Issue 1(2015:Apr.) Page Start: 34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗